Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 4 (April)

1. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.
   J Clin Oncol, 25(10): 1247-54. [Abstract] [Full-text]
2. "Demand the data! Your patients will ask and your practice will need it".
   Am J Gastroenterol, 102(4): 862-3. [Abstract] [Full-text]
3. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
   Eur J Cancer, 43(6): 1101-7. [Abstract] [Full-text]
4. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
   J Cell Physiol, 211(3): 826-36. [Abstract] [Full-text]
5. Definition of a direct extracellular interaction between Met and E-cadherin.
   Cell Biol Int, 31(4): 366-73. [Abstract] [Full-text]
6. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
   Am J Gastroenterol, 102(4): 803-13. [Abstract] [Full-text]
7. Does impaired TH1/TH2 balance cause postoperative infectious complications in colorectal cancer surgery?
   J Surg Res, 139(1): 15-21. [Abstract] [Full-text]
8. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival.
   Int J Cancer, 120(10): 2226-32. [Abstract] [Full-text]
9. Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines.
   Regul Pept, 141(1): 61-72. [Abstract] [Full-text]
10. Colon cancer management and outcome in relation to individual hospitals in a defined population.
    Br J Surg, 94(4): 491-9. [Abstract] [Full-text]
11. Mesenteric transection decreases expression of interstitial cells of Cajal in an experimental model.
    Br J Surg, 94(4): 483-90. [Abstract] [Full-text]
12. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy.
    Am J Gastroenterol, 102(4): 856-61. [Abstract] [Full-text]
13. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Am J Gastroenterol, 102(4): 829-36. [Abstract] [Full-text]
14. Dietary intake of B-vitamins, polymorphisms in thymidylate synthase and serine hydroxymethyltransferase 1, and colorectal adenoma risk: a Dutch case-control study.
    Cancer Lett, 250(1): 146-53. [Abstract] [Full-text]
15. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis.
    Cancer Lett, 250(1): 74-81. [Abstract] [Full-text]
16. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.
    Pharmacoepidemiol Drug Saf, 16(4): 393-401. [Abstract] [Full-text]
17. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.
    Psychooncology, 16(4): 320-8. [Abstract] [Full-text]
18. Stromal myofibroblasts predict disease recurrence for colorectal cancer.
    Clin Cancer Res, 13(7): 2082-90. [Abstract] [Full-text]
19. Patient participation in decision making: views of health professionals caring for people with colorectal cancer.
    J Clin Nurs, 16(4): 725-33. [Abstract] [Full-text]
20. The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.
    Clin Chim Acta, 380(1): 191-6. [Abstract] [Full-text]
21. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Clin Chim Acta, 380(1): 208-12. [Abstract] [Full-text]
22. Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis.
    Anal Biochem, 364(1): 37-50. [Abstract] [Full-text]
23. Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.
    Clin Chim Acta, 380(1): 128-32. [Abstract] [Full-text]
24. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases.
    Eur J Surg Oncol, 33(3): 329-35. [Abstract] [Full-text]
25. Repeat liver resection for recurrent liver metastases from colorectal cancer.
    Eur J Surg Oncol, 33(3): 324-8. [Abstract] [Full-text]
26. Therapeutic results in low-rectal cancer patients treated with abdominosacral resection are similar to those obtained by means of anterior resection in mid- and upper-rectal cancer cases.
    Eur J Surg Oncol, 33(3): 320-3. [Abstract] [Full-text]
27. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma.
    Br J Cancer, 96(7): 1118-26. [Abstract] [Full-text]
28. Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
    Br J Cancer, 96(7): 1043-6. [Abstract] [Full-text]
29. Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials.
    Br J Cancer, 96(7): 1030-6. [Abstract] [Full-text]
30. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing.
    Br J Cancer, 96(7): 1037-42. [Abstract] [Full-text]
31. The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases.
    Br J Cancer, 96(7): 1112-7. [Abstract] [Full-text]
32. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening.
    Int J Cancer, 120(11): 2281-9. [Abstract] [Full-text]
33. Mucin-depleted foci are modulated by dietary treatments and show deregulation of proliferative activity in carcinogen-treated rodents.
    Int J Cancer, 120(11): 2301-5. [Abstract] [Full-text]
34. Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer.
    Support Care Cancer, 15(5): 557-64. [Abstract] [Full-text]
35. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats.
    Am J Physiol Gastrointest Liver Physiol, 292(4): G1150-6. [Abstract] [Full-text]
36. Quality of life of Danish colorectal cancer patients with and without a stoma.
    Support Care Cancer, 15(5): 505-13. [Abstract] [Full-text]
37. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Cancer Res, 67(7): 3396-405. [Abstract] [Full-text]
38. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells.
    Cancer Res, 67(7): 3301-9. [Abstract] [Full-text]
39. Positron emission tomography of herpes simplex virus 1 oncolysis.
    Cancer Res, 67(7): 3295-300. [Abstract] [Full-text]
40. Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis.
    Cancer Res, 67(7): 3263-8. [Abstract] [Full-text]
41. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis.
    Cancer Res, 67(7): 3201-9. [Abstract] [Full-text]
42. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
    Cancer Res, 67(7): 3185-91. [Abstract] [Full-text]
43. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T.
    Biochem Biophys Res Commun, 356(3): 599-603. [Abstract] [Full-text]
44. Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells.
    BMC Cell Biol, 8: 12. [Abstract] [Full-text]
45. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
    Ann Surg, 245(4): 597-603. [Abstract] [Full-text]
46. Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.
    Ann Surg, 245(4): 583-90. [Abstract] [Full-text]
47. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
    Ann Surg, 245(4): 560-5. [Abstract] [Full-text]
48. Postoperative irradiation for rectal cancer increases the risk of small bowel obstruction after surgery.
    Ann Surg, 245(4): 553-9. [Abstract] [Full-text]
49. Immunohistochemical expression of p16 and Ki-67 correlates with degree of anal intraepithelial neoplasia.
    Am J Surg Pathol, 31(4): 555-61. [Abstract] [Full-text]
50. Diagnostic yield and safety of colonoscopy in Israeli patients in an open access referral system.
    J Clin Gastroenterol, 41(4): 394-9. [Abstract] [Full-text]
51. Induction of apoptosis and cell-cycle arrest in human colon cancer cells by meclizine.
    Food Chem Toxicol, 45(6): 935-44. [Abstract] [Full-text]
52. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
    Cancer Cell, 11(4): 335-47. [Abstract] [Full-text]
53. Insulin resistance-related genes and advanced left-sided colorectal adenoma.
    Cancer Epidemiol Biomarkers Prev, 16(4): 703-8. [Abstract] [Full-text]
54. Perceived risk of colorectal cancer: sources of risk judgments.
    Cancer Epidemiol Biomarkers Prev, 16(4): 694-702. [Abstract] [Full-text]
55. Dietary flavonoids and the risk of colorectal cancer.
    Cancer Epidemiol Biomarkers Prev, 16(4): 684-93. [Abstract] [Full-text]
56. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
    Cancer Epidemiol Biomarkers Prev, 16(4): 676-83. [Abstract] [Full-text]
57. Dietary fiber and risk of colorectal cancer in the Japan collaborative cohort study.
    Cancer Epidemiol Biomarkers Prev, 16(4): 668-75. [Abstract] [Full-text]
58. Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells.
    FEBS Lett, 581(8): 1649-56. [Abstract] [Full-text]
59. Detection of tissue abnormalities in normal mucosa surrounding colorectal cancer using an endocytoscopy system.
    Endoscopy, 39(4): 369-70. [Abstract] [Full-text]
60. Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation.
    Mol Cancer Res, 5(4): 341-9. [Abstract] [Full-text]
61. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study.
    Cancer Sci, 98(4): 590-7. [Abstract] [Full-text]
62. Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29).
    J Agric Food Chem, 55(8): 2892-900. [Abstract] [Full-text]
63. The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma.
    Endoscopy, 39(4): 309-13. [Abstract] [Full-text]
64. Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases.
    Cancer Lett, 250(2): 329-38. [Abstract] [Full-text]
65. Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
    Expert Rev Anticancer Ther, 7(4): 503-18. [Abstract] [Full-text]
66. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
    Expert Rev Anticancer Ther, 7(4): 489-501. [Abstract] [Full-text]
67. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
    Expert Rev Anticancer Ther, 7(4): 477-87. [Abstract] [Full-text]
68. Cetuximab plus irinotecan in refractory colorectal cancer patients.
    Expert Rev Anticancer Ther, 7(4): 407-13. [Abstract] [Full-text]
69. No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer.
    Oncogene, 26(17): 2513-7. [Abstract] [Full-text]
70. Rectal cancer and exposure to metalworking fluids in the automobile manufacturing industry.
    Occup Environ Med, 64(4): 244-9. [Abstract] [Full-text]
71. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells.
    Mol Cancer Ther, 6(4): 1433-9. [Abstract] [Full-text]
72. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
    Mol Cancer Ther, 6(4): 1276-82. [Abstract] [Full-text]
73. The surgical management of rectal cancer: a comparison of treatment methods and outcomes over 2 time periods in the same geographic region.
    Am J Surg, 193(5): 623-6; discussion 626. [Abstract] [Full-text]
74. The value of diverting loop ileostomy on the high-risk colon and rectal anastomosis.
    Am J Surg, 193(5): 585-7; discussion 587-8. [Abstract] [Full-text]
75. Laparoscopic colon surgery in community practice.
    Am J Surg, 193(5): 575-8; discussion 578-9. [Abstract] [Full-text]
76. Risk factors for impaired healing of the perineal wound after abdominoperineal resection of rectum for carcinoma.
    Colorectal Dis, 9(4): 362-7. [Abstract] [Full-text]
77. Outcomes in 2748 patients referred to a colorectal two-week rule clinic.
    Colorectal Dis, 9(4): 340-3. [Abstract] [Full-text]
78. Evaluating the accuracy of data entry in a regional colorectal cancer database: implications for national audit.
    Colorectal Dis, 9(4): 337-9. [Abstract] [Full-text]
79. Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia.
    Colorectal Dis, 9(4): 321-7. [Abstract] [Full-text]
80. Saving the sphincter in rectal cancer: are we prepared to change practice?
    Colorectal Dis, 9(4): 302-8; discussion 308-9. [Abstract] [Full-text]
81. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.
    Colorectal Dis, 9(4): 290-301. [Abstract] [Full-text]
82. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells.
    J Biol Chem, 282(16): 12249-59. [Abstract] [Full-text]
83. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
    J Surg Res, 139(2): 164-9. [Abstract] [Full-text]
84. Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR.
    Mol Cell Biochem, 298(1): 59-68. [Abstract] [Full-text]
85. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.
    Br J Cancer, 96(8): 1166-9. [Abstract] [Full-text]
86. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.
    Br J Cancer, 96(8): 1170-7. [Abstract] [Full-text]
87. Interstitial nephritis secondary to bevacizumab treatment in metastatic leiomyosarcoma.
    Ann Pharmacother, 41(4): 707-10. [Abstract] [Full-text]
88. Panitumumab: a fully human monoclonal antibody with activity in metastatic colorectal cancer.
    Ann Pharmacother, 41(4): 606-13. [Abstract] [Full-text]
89. Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas.
    Int J Cancer, 120(12): 2734-8. [Abstract] [Full-text]
90. Primary mucosal melanoma.
    J Am Acad Dermatol, 56(5): 828-34. [Abstract] [Full-text]
91. Panning and identification of a colon tumor binding peptide from a phage display peptide library.
    J Biomol Screen, 12(3): 429-35. [Abstract] [Full-text]
92. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer.
    Int J Cancer, 120(12): 2609-12. [Abstract] [Full-text]
93. Additional lymph node examination from entire submission of residual mesenteric tissue in colorectal cancer specimens may not add clinical and pathologic relevance.
    Hum Pathol, 38(5): 762-7. [Abstract] [Full-text]
94. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
    Cancer Res, 67(8): 3862-70. [Abstract] [Full-text]
95. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cancer Res, 67(8): 3835-44. [Abstract] [Full-text]
96. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
    Cancer Res, 67(8): 3569-73. [Abstract] [Full-text]
97. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
    Cancer Res, 67(8): 3551-4. [Abstract] [Full-text]
98. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
    Am J Clin Pathol, 127(5): 820-7. [Abstract] [Full-text]
99. Option appraisal of population-based colorectal cancer screening programmes in England.
    Gut, 56(5): 677-84. [Abstract] [Full-text]
100. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
101. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
     J Clin Oncol, 25(12): 1539-44. [Abstract] [Full-text]
102. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
     J Clin Oncol, 25(12): 1476-81. [Abstract] [Full-text]
103. Synchronous rectal and colon cancer caused by familial polyposis coli during pregnancy.
     J Obstet Gynaecol Res, 33(2): 199-202. [Abstract] [Full-text]
104. The effect of health literacy on knowledge and receipt of colorectal cancer screening: a survey study.
     BMC Fam Pract, 8: 16. [Abstract] [Full-text]
105. Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation.
     Oncogene, 26(18): 2535-42. [Abstract] [Full-text]
106. Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling.
     Oncogene, 26(18): 2642-8. [Abstract] [Full-text]
107. Novel APC mutations in Czech and Slovak FAP families: clinical and genetic aspects.
     BMC Med Genet, 8: 16. [Abstract] [Full-text]
108. Differences among the elderly in the treatment costs of colorectal cancer: how important is race?
     Med Care, 45(5): 420-30. [Abstract] [Full-text]
109. How do patients with colorectal cancer perceive treatment and care compared with the treating health care professionals?
     Med Care, 45(5): 394-400. [Abstract] [Full-text]
110. Different mechanisms can lead to the same altered HLA class I phenotype in tumors.
     Tissue Antigens, 69: 259-63. [Abstract] [Full-text]
111. Age-related analysis of functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis.
     J Gastroenterol Hepatol, 22(5): 710-4. [Abstract] [Full-text]
112. Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.
     BMC Cancer, 7: 58. [Abstract] [Full-text]
113. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial.
     Clin Gastroenterol Hepatol, 5(4): 477-83. [Abstract] [Full-text]
114. Local radiofrequency ablation techniques for liver metastases of colorectal cancer.
     Crit Rev Oncol Hematol, 62(2): 153-63. [Abstract] [Full-text]
115. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
     Clin Gastroenterol Hepatol, 5(4): 470-6; quiz 407. [Abstract] [Full-text]
116. Results of laparoscopic surgery for colorectal cancer in palliative intent: short-term end points in 331 patients in comparison with procedures in benign indications.
     Surg Laparosc Endosc Percutan Tech, 17(2): 79-82. [Abstract] [Full-text]
117. Developing strategies for liver metastases from colorectal cancer.
     Semin Oncol, 34(2): S7-11. [Abstract] [Full-text]
118. Adjuvant therapy for stage II and III colorectal cancer.
     Semin Oncol, 34(2): S37-40. [Abstract] [Full-text]
119. Follow-up of patients with colorectal cancer: the evidence is in favour but we are still in need of a protocol.
     Int J Surg, 5(2): 120-8. [Abstract] [Full-text]
120. Treatment combining X-irradiation and a ribonucleoside anticancer drug, TAS106, effectively suppresses the growth of tumor cells transplanted in mice.
     Int J Radiat Oncol Biol Phys, 68(1): 218-28. [Abstract] [Full-text]
121. In vivo observation of pulmonary micrometastasis of colon cancer in normal rats.
     Microvasc Res, 73(3): 206-13. [Abstract] [Full-text]
122. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall.
     Gynecol Oncol, 105(2): 395-8. [Abstract] [Full-text]
123. Anti-cancer properties of phenolics from apple waste on colon carcinogenesis in vitro.
     Food Chem Toxicol, 45(7): 1224-30. [Abstract] [Full-text]
124. Functional results and quality of life for patients with very low rectal cancer undergoing coloanal anastomosis or perineal colostomy with colonic muscular graft.
     Eur J Surg Oncol, 33(4): 459-62. [Abstract] [Full-text]
125. Prognostic influence of multiple hepatic metastases from colorectal cancer.
     Eur J Surg Oncol, 33(4): 468-73. [Abstract] [Full-text]
126. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer.
     Eur J Surg Oncol, 33(4): 463-7. [Abstract] [Full-text]
127. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
     Eur J Surg Oncol, 33(4): 452-8. [Abstract] [Full-text]
128. Modified Irinotecan/5FU/Leucovorin therapy in advanced colorectal cancer and predicting therapeutic efficacy by expression of tumor-related enzymes.
     Scand J Gastroenterol, 42(4): 477-84. [Abstract] [Full-text]
129. Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
     Scand J Gastroenterol, 42(4): 471-6. [Abstract] [Full-text]
130. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution.
     Acta Radiol, 48(4): 379-87. [Abstract] [Full-text]
131. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
     Acta Radiol, 48(4): 369-78. [Abstract] [Full-text]
132. Radiofrequency ablation of colorectal liver metastases: long-term survival.
     Acta Radiol, 48(3): 253-8. [Abstract] [Full-text]
133. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
     Clin Nucl Med, 32(5): 361-2. [Abstract] [Full-text]
134. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
     Mutat Res, 619(1): 68-80. [Abstract] [Full-text]
135. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
     J Immunother (1997), 30(4): 359-69. [Abstract] [Full-text]
136. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.
     Ann Surg, 245(5): 726-33. [Abstract] [Full-text]
137. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
     Radiol Med (Torino), 112(3): 319-28. [Abstract] [Full-text]
138. Local excision of rectal tumours by transanal endoscopic microsurgery.
     Br J Surg, 94(5): 627-33. [Abstract] [Full-text]
139. Radiosynthesis of 18F-(R8,15,21, L17)-vasoactive intestinal peptide and preliminary evaluation in mice bearing C26 colorectal tumours.
     Nucl Med Commun, 28(6): 501-6. [Abstract] [Full-text]
140. A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
     Nucl Med Commun, 28(6): 485-93. [Abstract] [Full-text]
141. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
     Immunity, 26(4): 461-75. [Abstract] [Full-text]
142. Randomized trial of health-related quality of life after open and laparoscopic surgery for colon cancer.
     Surg Endosc, 21(5): 747-53. [Abstract] [Full-text]
143. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
     Cancer Immunol Immunother, 56(7): 985-95. [Abstract] [Full-text]
144. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells.
     Carcinogenesis, 28(5): 1021-31. [Abstract] [Full-text]
145. A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.
     Cancer Immunol Immunother, 56(7): 973-84. [Abstract] [Full-text]
146. Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer.
     Carcinogenesis, 28(5): 968-76. [Abstract] [Full-text]
147. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
     Cancer Immunol Immunother, 56(7): 1025-36. [Abstract] [Full-text]
148. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma.
     Carcinogenesis, 28(5): 1122-30. [Abstract] [Full-text]
149. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D.
     Carcinogenesis, 28(5): 922-31. [Abstract] [Full-text]
150. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
     Oncogene, 26(19): 2781-90. [Abstract] [Full-text]
151. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer.
     Nat Clin Pract Oncol, 4(5): 316-21. [Abstract] [Full-text]
152. Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures.
     Ann Epidemiol, 17(5): 394-9. [Abstract] [Full-text]
153. 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
     Free Radic Biol Med, 42(11): 1661-70. [Abstract] [Full-text]
154. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women.
     Am J Epidemiol, 165(10): 1178-86. [Abstract] [Full-text]
155. Randomized clinical trial comparing intravenous antimicrobial prophylaxis alone with oral and intravenous antimicrobial prophylaxis for the prevention of a surgical site infection in colorectal cancer surgery.
     Surg Today, 37(5): 383-8. [Abstract] [Full-text]
156. Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back.
     Lancet Oncol, 8(5): 439-43. [Abstract] [Full-text]
157. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study.
     Lancet Oncol, 8(5): 387-94. [Abstract] [Full-text]
158. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
     Gastroenterology, 132(4): 1420-31. [Abstract] [Full-text]
159. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
     Gastroenterology, 132(4): 1254-60. [Abstract] [Full-text]
160. No evidence for association of NOD2 R702W and G908R with colorectal cancer.
     Int J Cancer, 121(1): 76-9. [Abstract] [Full-text]
161. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines.
     Int J Cancer, 121(1): 175-83. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.